Guido Mitchell

MedTech Commercial Leader | Medical Devices · Diabetes Care | CCO · VP Commercial · GM | Growth · Turnarounds & Transformation | 9-figure P&L | Europe & Global

Zürich Metropolitan Area

About

I build commercial engines that scale — and fix the ones that don't. With more than 25 years in medical devices and technology-enabled healthcare across Europe, North America, and emerging markets, I specialize in three things: accelerating growth in competitive regulated markets, turning around underperforming commercial operations, and leading the complex organizational transformations that make both possible. At ViCentra, I scaled the active patient base to 5,000 across Germany, France, and the Netherlands — with distributor management frameworks and commercial infrastructure now in place supporting the next growth phase — and built the investor relations credibility that helped secure $98M in total financing. At Roche Canada, I reversed three years of profit erosion into +9% annual net profit growth by cutting COGS by 12%, sales costs by 22%, and marketing costs by 25% — without sacrificing market position. And as commercial lead for Roche's global "Autonomy & Speed" transformation, I stood up a new 6,000-person organization across 52 countries, delivering 18% under a 150M CHF budget. Core expertise spans commercial excellence, distributor management, and market access across EMEA and North America — with hands-on experience in AID-enabled insulin pumps, CGM, blood glucose monitoring, digital health, and technology-enabled diabetes care. Equally effective in scale-up environments and large matrix organizations. Currently open to Chief Commercial Officer and senior commercial leadership roles in MedTech — across both scale-ups and established organizations — globally, including relocation.

Experience

  • ViCentra (2 yrs 7 mos)
    • VP of Commercial | Growth · P&L · MedTech | Europe
      Mar 2024 - May 2026 · 2 yrs 3 mos

      Team: 35+ │ 8 direct reports │ 8-figure P&L ▪ Scaled active patient base to 5,000 while creating the commercial foundation for the next growth phase ▪ Built investor confidence that contributed directly to $98M in total financing, demonstrating commercial execution credibility ahead of US market entry ▪ Designed and deployed a distributor framework — covering scorecards, pricing architecture, commercial terms, and financial controls — across three markets simultaneously ▪ Grew the German affiliate from 8 to 30+ team members while serving concurrently as Interim Country Manager, maintaining zero disruption to commercial momentum

    • Country Manager, Germany | Market Entry · Growth
      Nov 2023 - Feb 2024 · 4 mos

      Successful market entry in Germany's highly competitive insulin pump segment — promoted to VP of Commercial within four months. Team: 8+ │ 4 direct reports │ Market entry from zero │ 10–15% new user share Year 1 ▪ Captured 10–15% new user share in Year 1 in Germany's highly competitive insulin pump market — entering from zero ▪ Achieved 100% coverage of all potential users through a proprietary commercial framework developed and implemented within the first year ▪ Built and operationalized a multi-partner distributor network from scratch, creating the commercial foundation for the broader European expansion

  • Roche (23 yrs 4 mos)
    • DC Special Projects | Roche Diabetes Care HQ
      Jan 2020 - Feb 2023 · 3 yrs 2 mos

      Retained at Roche Diabetes Care HQ following the Canada assignment, leading strategic projects in commercial excellence and business transformation during a period of divisional restructuring.

    • General Manager, Canada | Diabetes Care · P&L · Turnaround
      May 2017 - Dec 2019 · 2 yrs 8 mos

      Reversed three consecutive years of profit erosion into +9% annual net profit growth across a complex, regionalized 9-figure P&L. Team: 80+ │ 6 direct reports │ 9-figure P&L │ Top 9 global sales ranking ▪ Reduced COGS by 12%, sales costs by 22%, and marketing costs by 25% through disciplined portfolio streamlining, remote coverage models, and procurement reform ▪ Launched a smart blood glucose meter with an integrated digital channel strategy, capturing 5% market share in Year 1 in a crowded segment ▪ Secured a landmark partnership with Medavie Blue Cross, embedding the mySugr digital diabetes management app as a premium benefit for their customer base ▪ Transformed people engagement from 54% to 92% in under two years through an agile leadership culture and structured development programs

    • VP, Global Commercial Strategy & Operations | Diabetes Care · Transformation
      Jul 2014 - Apr 2017 · 2 yrs 10 mos

      Team: 120+ │ 10 direct reports │ Commercial budget: 150M CHF ▪ Served as commercial lead for "Autonomy & Speed" — carving out Roche Diabetes Care (~2.5Bn CHF revenue) into a standalone entity of 6,000 people across 52 countries ▪ Designed the commercial operating model granting full independence to 52 affiliates for the first time in the division's history ▪ Delivered the full commercial rollout on time and 18% under a 150M CHF transformation budget ▪ Implemented SAP and Salesforce end-to-end, establishing standardized business processes globally

  • Business Development Intern, Asia at BASF
    1996 - 1997 · 1 yr